Personal information

drug delivery, nanoparticles, liposomes, pharmacokinetics
Canada

Activities

Employment (1)

Université Laval Faculté de pharmacie: Laval, QC, CA

2015-01-23 to present | Professor
Employment
Source: Self-asserted source
Nicolas Bertrand

Education and qualifications (2)

Massachusetts Institute of Technology David H Koch Institute for Integrative Cancer Research: Cambridge, MA, US

2011-09-01 to 2015-01-22 | Postdoctoral Fellow
Education
Source: Self-asserted source
Nicolas Bertrand

Université de Montréal: Montreal, QC, CA

2006-09-01 to 2011-07-14 | PhD (Faculté de Pharmacie)
Education
Source: Self-asserted source
Nicolas Bertrand

Funding (7)

Causes and consequences of anti-PEG antibodies

2023 to 2028 | Grant
Canadian Institutes of Health Research (ON, ON, CA)
Source: Self-asserted source
Nicolas Bertrand

Methods to study the long-term effects of nanoparticles in vivo

2023 to 2028 | Grant
Natural Sciences and Engineering Research Council (Ottawa, CA)
Source: Self-asserted source
Nicolas Bertrand

Causes and consequences of anti-PEG antibodies

2023 to 2024 | Grant
Canadian Institutes of Health Research (ON, ON, CA)
Source: Self-asserted source
Nicolas Bertrand

Nanomedicine to streamline the development of endoplasmic reticulum stress aggravator

2017-03 to 2018-03 | Grant
Fonds de Recherche du Québec - Santé (QC, QC, CA)
Source: Self-asserted source
Nicolas Bertrand

Functional polymers and libraries of nanoparticles for drug delivery

2016-11 to 2018-03 | Grant
Canada Foundation for Innovation (ON, ON, CA)
Source: Self-asserted source
Nicolas Bertrand

Quaternized trimethyl chitosan nanoparticles to encapsulate peptides with poor oral bioavailability

2016-10 to 2017-05 | Grant
Natural Sciences and Engineering Research Council of Canada (Ottawa, CA)
Source: Self-asserted source
Nicolas Bertrand

Engineering functional nanoparticles using libraries of polymers

2016-06 to 2021-05 | Grant
Natural Sciences and Engineering Research Council of Canada (Ottawa, CA)
Source: Self-asserted source
Nicolas Bertrand

Peer review (174 reviews for 33 publications/grants)

Review activity for ACS nano. (7)
Review activity for Acta biomaterialia. (9)
Review activity for Advanced drug delivery reviews. (6)
Review activity for Advanced therapeutics. (2)
Review activity for Angewandte Chemie. (1)
Review activity for Angewandte Chemie. (3)
Review activity for Biochimica et biophysica acta (2)
Review activity for Bioconjugate chemistry. (1)
Review activity for Biomaterials. (2)
Review activity for Colloids and surfaces. (1)
Review activity for Communications chemistry. (3)
Review activity for Environmental pollution. (1)
Review activity for European journal of pharmaceutics and biopharmaceutics. (10)
Review activity for International journal of molecular sciences. (1)
Review activity for Journal of controlled release. (11)
Review activity for Journal of controlled release. (55)
Review activity for Journal of functional foods. (2)
Review activity for Journal of nanomaterials. (1)
Review activity for JoVE. (2)
Review activity for Materials science & engineering. (4)
Review activity for Molecular membrane biology (1)
Review activity for Molecular pharmaceutics. (18)
Review activity for Molecular pharmaceutics. (15)
Review activity for Nanomedicine. (1)
Review activity for Nanoscale advances. (2)
Review activity for Nanoscale. (1)
Review activity for Nature communications (2)
Review activity for Nature nanotechnology (1)
Review activity for Pharmaceutics. (2)
Review activity for Proceedings of the National Academy of Sciences of the United States of America. (1)
Review activity for Small. (4)
Review activity for Soft matter. (1)
Review activity for Theranostics (1)